Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy [5]

Blood

Volumn 100, Issue 8, 2002, Pages 3054-

  Lau, George K K ^a   Lie, Albert ^a   Liang, Raymond ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GLUCOCORTICOID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; VIRUS DNA;

ANTIGEN SPECIFICITY; CHRONIC HEPATITIS; DISEASE EXACERBATION; DNA DETERMINATION; DRUG CYTOTOXICITY; HEPATITIS B; HORMONE RESPONSIVE ELEMENT; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SEQUENCE ANALYSIS; SERODIAGNOSIS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0037108429     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-1976     Document Type: Letter

References (8)

1. Shibolet O, Ilan Y, Gillis S, Hubert A, Shouval D, Safadi R. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood. 2002;100:391-396.
2. Liang R, Lau GKK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol. 1999;17:394-398.
3. Yeo W, Steinberg JL, Tam JS, et al. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. J Med Virol. 1999;59:263-269.
4. Lau GKK, Liang RHS, Wu PC, Lee CK, Lim WL, Au WY. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. J Hepatol. 1998;28:359-368.
5. Steinberg JL, Yeo W, Zhong S, et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role. J Med Virol. 2000;60:249-255.
6. Colloredo MG, Bellati G, Leandro G, et al. Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol Suppl. 1993;8:203-211.
7. Tur Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A. 1986;83:1627-1631.
8. Lau GK, Leung YH, Fong DY, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood. 2002;99:2324-2330.